Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.

Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW.

Cancer. 2016 Oct;122(19):2971-8. doi: 10.1002/cncr.30153. Epub 2016 Jun 28.

2.

Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast.

Catsburg C, Gunter MJ, Tinker L, Chlebowski RT, Pollak M, Strickler HD, Cote ML, Page DL, Rohan TE.

J Cancer Epidemiol. 2015;2015:203284. doi: 10.1155/2015/203284. Epub 2015 May 28.

3.

Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up.

Sanders ME, Schuyler PA, Simpson JF, Page DL, Dupont WD.

Mod Pathol. 2015 May;28(5):662-9. doi: 10.1038/modpathol.2014.141. Epub 2014 Dec 12.

4.

Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.

Catsburg C, Gunter MJ, Chen C, Cote ML, Kabat GC, Nassir R, Tinker L, Wactawski-Wende J, Page DL, Rohan TE.

Cancer Res. 2014 Jun 15;74(12):3248-58. doi: 10.1158/0008-5472.CAN-13-3514. Epub 2014 Apr 22.

5.

Intranodal papillary epithelial proliferations: a local process with a spectrum of morphologies and frequent association with papillomas in the breast.

Boulos FI, Granja NM, Simpson JF, O'Malley FP, Saadeldine MM, Page DL, Sanders ME.

Am J Surg Pathol. 2014 Mar;38(3):383-8. doi: 10.1097/PAS.0000000000000115. Erratum in: Am J Surg Pathol. 2014 May;38(5):728. Sanders, Melina E [corrected to Sanders, Melinda E].

PMID:
24525508
6.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.

Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, Cherbavaz DB, Shak S, Page DL, Sledge GW Jr, Davidson NE, Ingle JN, Perez EA, Wood WC, Sparano JA, Badve S.

J Natl Cancer Inst. 2013 May 15;105(10):701-10. doi: 10.1093/jnci/djt067. Epub 2013 May 2.

7.

A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24.

Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1565-73. doi: 10.1158/1055-9965.EPI-12-0386. Epub 2012 Jul 17.

8.

Grading breast cancer on microarray samples: comparison with Nottingham grade, and use of boosting classification.

Dalton L, Page DL.

Histopathology. 2012 Sep;61(3):497-508. doi: 10.1111/j.1365-2559.2012.04254.x. Epub 2012 May 31.

PMID:
22651792
9.

Outdoor scene image segmentation based on background recognition and perceptual organization.

Cheng C, Koschan A, Chen CH, Page DL, Abidi MA.

IEEE Trans Image Process. 2012 Mar;21(3):1007-19. doi: 10.1109/TIP.2011.2169268. Epub 2011 Sep 23.

PMID:
21947522
10.

Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions: evidence against a precursor role.

Boulos FI, Dupont WD, Schuyler PA, Sanders ME, Page DL, Fedda FA, Simpson JF.

Cancer. 2012 May 1;118(9):2372-7. doi: 10.1002/cncr.26523. Epub 2011 Sep 14.

11.

Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.

Crooke PS, Justenhoven C, Brauch H; GENICA Consortium, Dawling S, Roodi N, Higginbotham KS, Plummer WD, Schuyler PA, Sanders ME, Page DL, Smith JR, Dupont WD, Parl FF.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1502-15. doi: 10.1158/1055-9965.EPI-11-0060. Epub 2011 May 24.

12.

A multistage association study identifies a breast cancer genetic locus at NCOA7.

Higginbotham KS, Breyer JP, Bradley KM, Schuyler PA, Plummer WD Jr, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Sanders ME, Page DL, Parl FF, Egan KM, Dupont WD, Smith JR.

Cancer Res. 2011 Jun 1;71(11):3881-8. doi: 10.1158/0008-5472.CAN-10-2653. Epub 2011 May 24.

13.

Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk.

Dupont WD, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Sanders ME, Page DL, Smith JR.

Cancer. 2010 Jan 1;116(1):8-19. doi: 10.1002/cncr.24702. Erratum in: Cancer. 2010 Apr 1;116(7):1840.

14.

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, Lowen MA, Ingle JN, Recht A, Wood WC.

J Clin Oncol. 2009 Nov 10;27(32):5319-24. doi: 10.1200/JCO.2009.21.8560. Epub 2009 Oct 13.

15.

Protocol for the examination of specimens from patients with invasive carcinoma of the breast.

Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, Smith BL, Tan LK, Weaver DL, Winer E; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2009 Oct;133(10):1515-38. doi: 10.1043/1543-2165-133.10.1515. No abstract available.

PMID:
19792042
16.

Syringomatous adenoma of the nipple occurring within a supernumerary breast: a case report.

Page RN, Dittrich L, King R, Boulos F, Page DL.

J Cutan Pathol. 2009 Nov;36(11):1206-9. doi: 10.1111/j.1600-0560.2009.01267.x.

PMID:
19469876
17.

Heritable variation of ERBB2 and breast cancer risk.

Breyer JP, Sanders ME, Airey DC, Cai Q, Yaspan BL, Schuyler PA, Dai Q, Boulos F, Olivares MG, Bradley KM, Gao YT, Page DL, Dupont WD, Zheng W, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1252-8. doi: 10.1158/1055-9965.EPI-08-1202. Epub 2009 Mar 31.

18.

Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial.

Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, Ginsberg M, Lane DS, Neuhouser ML, Shikany JM, Wassertheil-Smoller S, Page DL.

Cancer Prev Res (Phila). 2008 Sep;1(4):275-84. doi: 10.1158/1940-6207.CAPR-08-0003. Epub 2008 Jul 9.

19.

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.

Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, Smith BL, Weaver DL, Winer E; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2009 Jan;133(1):15-25. doi: 10.1043/1543-2165-133.1.15. No abstract available.

PMID:
19123730
20.

Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent breast implants.

Williams GM, Caldwell J, Armstrong D, Bartsch H, Bevan R, Browne RW, Chipman JK, Iatropoulos MJ, Jeffrey AM, Lunec J, Nair J, Page DL, Reeves BC, Richardson A, Silverstein B, Williams DF.

Regul Toxicol Pharmacol. 2009 Mar;53(2):107-20. doi: 10.1016/j.yrtph.2008.10.009. Epub 2008 Nov 7.

PMID:
19027814
21.

A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.

Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS, Ginsberg M, Wassertheil-Smoller S, Page DL.

Breast Cancer Res Treat. 2009 Jul;116(2):339-50. doi: 10.1007/s10549-008-0213-0. Epub 2008 Oct 14.

22.

Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study.

Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL.

Cancer. 2008 Nov 1;113(9):2415-21. doi: 10.1002/cncr.23873.

23.

Estrogen plus progestin and risk of benign proliferative breast disease.

Rohan TE, Negassa A, Chlebowski RT, Lasser NL, McTiernan A, Schenken RS, Ginsberg M, Wassertheil-Smoller S, Page DL.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2337-43. doi: 10.1158/1055-9965.EPI-08-0380. Epub 2008 Aug 25.

24.

Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.

Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL.

J Natl Cancer Inst. 2008 Apr 16;100(8):563-71. doi: 10.1093/jnci/djn075. Epub 2008 Apr 8. Erratum in: J Natl Cancer Inst. 2008 May 21;100(10):754.

PMID:
18398105
25.

Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.

Cui Y, Page DL, Lane DS, Rohan TE.

Breast Cancer Res Treat. 2009 Mar;114(1):113-20. doi: 10.1007/s10549-008-9973-9. Epub 2008 Mar 22.

PMID:
18360772
26.

Point fingerprint: a new 3-D object representation scheme.

Sun Y, Paik J, Koschan A, Page DL, Abidi MA.

IEEE Trans Syst Man Cybern B Cybern. 2003;33(4):712-7. doi: 10.1109/TSMCB.2003.814295.

PMID:
18238221
27.

Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast.

Cui Y, Page DL, Chlebowski RT, Beresford SA, Hendrix SL, Lane DS, Rohan TE.

Int J Cancer. 2007 Sep 15;121(6):1346-51.

28.

Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative.

Cui Y, Page DL, Chlebowski RT, Hsia J, Allan Hubbell F, Johnson KC, Rohan TE.

Cancer Causes Control. 2007 May;18(4):431-8. Epub 2007 Feb 24.

PMID:
17323143
29.

Diabetic (lymphocytic) mastopathy with exuberant lymphohistiocytic and granulomatous response: a case report with review of the literature.

Fong D, Lann MA, Finlayson C, Page DL, Singh M.

Am J Surg Pathol. 2006 Oct;30(10):1330-6.

PMID:
17001167
30.

Gray-level grouping (GLG): an automatic method for optimized image contrast enhancement--Part II: the variations.

Chen Z, Abidi BR, Page DL, Abidi MA.

IEEE Trans Image Process. 2006 Aug;15(8):2303-14.

PMID:
16900685
31.

Gray-level grouping (GLG): an automatic method for optimized image contrast enhancement--Part I: the basic method.

Chen Z, Abidi BR, Page DL, Abidi MA.

IEEE Trans Image Process. 2006 Aug;15(8):2290-302.

PMID:
16900684
32.

Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Lagios MD, Page DL, Silverstein MJ.

J Clin Oncol. 2006 Aug 10;24(23):3809-11; author reply 3811-2. No abstract available.

PMID:
16896011
33.

Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy.

McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL.

Cancer. 2006 Sep 15;107(6):1227-33.

34.

Why I became a surgical pathologist with interest in breast disease.

Page DL.

J Clin Pathol. 2007 Mar;60(3):251-2. Epub 2006 May 26.

35.

Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact.

Carter BA, Page DL.

J Clin Oncol. 2006 May 1;24(13):1978-9. Epub 2006 Apr 10. No abstract available.

PMID:
16606969
36.

Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.

Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD.

Cancer. 2006 Apr 1;106(7):1453-61.

37.

Image-detected breast cancer: state of the art diagnosis and treatment.

Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, Holmes DR, Hughes LL, Jackman RJ, Julian TB, Kuerer HM, Mabry HC, McCready DR, McMasters KM, Page DL, Parker SH, Pass HA, Pegram M, Rubin E, Stavros AT, Tripathy D, Vicini F, Whitworth PW.

J Am Coll Surg. 2005 Oct;201(4):586-97. Review. No abstract available.

PMID:
16183499
38.

Adenomyoepithelioma: clinical, histologic, and immunohistologic evaluation of a series of related lesions.

McLaren BK, Smith J, Schuyler PA, Dupont WD, Page DL.

Am J Surg Pathol. 2005 Oct;29(10):1294-9.

PMID:
16160470
39.

Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis.

Page DL.

Breast Cancer Res Treat. 2005 Oct;93(3):189-90. No abstract available.

PMID:
16142443
40.

What is atypical lobular hyperplasia and what does it mean for the patient?

Page DL, Simpson JF.

J Clin Oncol. 2005 Aug 20;23(24):5432-3. No abstract available.

PMID:
16110003
42.

Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Edge SB, Sobin LH, Page DL, Gospodarowicz MK, Greene FL, Winchester DP.

J Natl Cancer Inst. 2005 Mar 16;97(6):463-4; author reply 464-5. No abstract available.

PMID:
15770013
43.

Apocrine carcinomas of the breast.

Page DL.

Breast. 2005 Feb;14(1):1-2. No abstract available.

44.

Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study.

McLaren BK, Gobbi H, Schuyler PA, Olson SJ, Parl FF, Dupont WD, Page DL.

Am J Surg Pathol. 2005 Jan;29(1):105-8.

PMID:
15613861
45.

Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units.

Gobbi H, Dupont WD, Parl FF, Schuyler PA, Plummer WD, Olson SJ, Page DL.

Int J Cancer. 2005 Feb 20;113(5):857-9.

46.

Lobulocentricity of breast hypersecretory hyperplasia with cytologic atypia: infrequent association with carcinoma in situ.

Kasami M, Jensen RA, Simpson JF, Page DL.

Am J Clin Pathol. 2004 Nov;122(5):714-20.

PMID:
15491967
47.

Phyllodes tumor of the breast: local recurrence versus metastatic capacity.

Carter BA, Page DL.

Hum Pathol. 2004 Sep;35(9):1051-2. Review. No abstract available.

PMID:
15343504
48.

Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.

Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ; Radiologist Investigators of the Radiologic Diagnostic Oncology Group V.

Acad Radiol. 2004 Mar;11(3):293-308.

PMID:
15035520
49.

Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America.

Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA.

Mod Pathol. 2004 May;17(5):489-95.

50.

Breast lesions, pathology and cancer risk.

Page DL.

Breast J. 2004 Jan-Feb;10 Suppl 1:S3-4. Review.

PMID:
14984480

Supplemental Content

Support Center